Ovid Therapeutics Inc. ($OVID)
Filing Information
| Accession Number | 0001311404-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
485,416
Total Value
$12,384.45
P&L
+inf% (+$939,443.75)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CBFO | Common Stock | โ | Feb 23, 2026 | Sale | 8,541 | $1.45 | $12,384.45 | 88,188 | Direct | โ | View Details | |
CBFO | Common Stock | โ | Feb 26, 2026 | Grant/Award | 68,125 | $0.00 | $0.00 | 156,313 | Direct | โ | View Details | |
CBFO | Employee Stock Option (Right to Buy) | Derivative | Feb 26, 2026 | Grant/Award | 408,750 | $0.00 | $0.00 | 408,750 | Direct | โ | View Details |